*(HealthDay News via Yahoo News) — Researchers studying the link between diabetes and a hormone that affects your so-called “body clock” have identified a genetic mutation in the receptor for the hormone, melatonin, that may to boost the risk of the disease.
The finding could help improve assessment of a person’s diabetes risk and could also lead to the development of personalized treatments, according to the study published in the Jan. 29 online edition of the journal Nature Genetics.
The research team from Imperial College London found that people who have rare genetic mutations in the receptor for melatonin have a greatly increased risk for type 2 diabetes.
Melatonin controls the body’s sleep-wake cycle. A previous study found that people with common variations in the gene for the melatonin receptor MT2 have a slightly increased risk for type 2 diabetes.
This new study discovered that having any of four rare mutations of the MT2 is associated with a six times increased risk of developing type 2 diabetes.
Read/learn more at Yahoo News.
Want to read more articles like this one? Subscribe to EURnewsletter.
Got A News Tip or Video You Want to Share? Contact us HERE.
- Lamar Sally: ‘Sherri Shepherd Has Made My Life A Living Hell’
- Super Bowl 50: As Seen From Beyonce’s Instagram
- 'Wendy's Style Squad' Coming to BET
- Bills RB LeSean McCoy Scraps With 3 Off-Duty Cops Over Bubbly
- Flavor Flav to Face Vegas Judge in DUI Case
- TV One's 'News Now' Devotes Show to NAACP Image Awards
- Derek Fisher Fired As Head Coach of the Knicks
- Claudia Jordan on Jealous 'The Next :15' Cast & Calling Black Women 'Monkeys' [EUR Exclusive]
- Could Whoopi Goldberg’s ‘Slave’ Mentality Get Her Fired From ‘The View’?
- Twitter CEO Urges Calmness Due to Angry Tweets, Says Not Much Will Change
- Discover More Stories on EURweb: Click Here